SUMOylation of PPARγ by Rosiglitazone Prevents LPS-Induced NCoR Degradation Mediating Down Regulation of Chemokines Expression in Renal Proximal Tubular Cells-Reference-Cited by-同舟云学术

SUMOylation of PPARγ by Rosiglitazone Prevents LPS-Induced NCoR Degradation Mediating Down Regulation of Chemokines Expression in Renal Proximal Tubular Cells

Published:2013-11-08 Issue:11 Volume:8 Page:e79815
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lu Ying,Zhou Qiao,Shi Yongbing,Liu Jian,Zhong Fang,Hao Xu,Li Cong,Chen Nan,Wang Weiming

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference22 articles.

1. Effect of 15d-PGJ2 on the expression of CD40 and RANTES induced by IFN-gamma and TNF-alpha on renal tubular epithelial cells (HK-2);YJ Zhang;Am J Nephrol,2006

2. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists;HJ Anders;Kidney Int,2006

3. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies;S Segerer;J Am Soc Nephrol,2000

4. The many faces of PPARgamma;M Lehrke;Cell,2005

5. The many faces of PPARgamma: anti-inflammatory by any means?;A Szanto;Immunobiology,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The crosstalk between SUMOylation and immune system in host-pathogen interactions;Critical Reviews in Microbiology;2024-04-15

2. Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study;International Journal of Molecular Sciences;2024-03-15

3. N-methyladenosine-modified PIAS1 promotes microglia polarization to M1 by regulating PPARγ SUMOylation in Inflammatory Bowel Disease-associated hyperalgesia;2023-09-09

4. Evidence Linking PPARG Genetic Variants with Periodontitis and Type 2 Diabetes Mellitus in a Brazilian Population;International Journal of Molecular Sciences;2023-04-05

5. Natural Products Against Renal Fibrosis via Modulation of SUMOylation;Frontiers in Pharmacology;2022-03-04